Table 5 Factors associated with a change of Hb among VL patients at UoG-LRTC and MSF-KTC northwest Ethiopia, 2017
Independent variables | (B) Coefficients/std-error | 95% (CI for B) | P-value | |
|---|---|---|---|---|
Lower | Upper | |||
Constant | 6.866/0.397 | 6.085 | 7.646 | < 0.0001 |
SSG-PM treatment | 0.710/0.15 | 0.416 | 1.005 | < 0.0001 |
Age | −0.030/0.009 | −0.049 | −0.012 | 0.001 |
Nasal bleeding | −0.261/0.123 | − 0.502 | − 0.019 | 0.035 |
Baseline WBC | − 0.139/0.044 | − 0.226 | − 0.052 | 0.002 |
Baseline Hb | − 0.513/0.031 | − 0.574 | − 0.452 | < 0.0001 |
End of treatment spleen size | − 0.059/0.015 | − 0.088 | − 0.029 | < 0.0001 |
Iron-folic acid supplementation | − 0.574/0.163 | −0.895 | − 0.253 | < 0.0001 |